The Long Run with Luke Timmerman
MurmurCast publishes AI-generated summaries of The Long Run with Luke Timmerman’s Podcast episodes — 3 summarized so far, covering Career progression from law to biotech leadership, LB102 drug development and mechanism of action, Schizophrenia and neuropsychiatric disorder treatment, Biotech IPO during financing freeze, Clinical trial design and placebo management, Patient adherence in mental health treatment. Each summary distills the key insights, topics, and takeaways so you can decide what’s worth your time before pressing play.
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
Heather Turner, CEO of LB Pharmaceuticals, discusses her unconventional path from corporate attorney to biotech CEO, leading the development of LB102, a methylated derivative of amisulpride for treating schizophrenia and other neuropsychiatric disorders. She successfully navigated a challenging IPO during a biotech financing freeze and is now advancing the compound through late-stage clinical trials with a focus on improving patient adherence and reducing side effects.
Ep204: Troy Wilson on Precision Cancer Drugs and Combos
Troy Wilson, CEO of Cura Oncology, discusses his journey from mediocre student to serial biotech entrepreneur, the development of Ziftimenib (a Menin inhibitor approved for AML), and the company's strategy of combining precision cancer drugs like farnesyl transferase inhibitors with emerging RAS inhibitors to overcome treatment resistance.
Ep201: Jeremy Levin on Biotech in the Balance
Jeremy Levin, founder of Ovid Therapeutics and author of 'Biotech in the Balance,' discusses the systemic decline in public trust toward the biotechnology industry, tracing it from the Shkreli scandal through COVID-19 and into the current era of hostile policy. He argues the industry must recognize itself as strategically vital and offers ten commitments—including transparency, patient-centricity, and long-term capital formation—to rebuild its standing with the public and policymakers.